Literature DB >> 1921231

Long-term effect of intensified insulin treatment on lipid parameters in diabetes mellitus type I.

A Dzien1, M Lechleitner, T Hopferwieser, H Drexel, J R Patsch, H Braunsteiner.   

Abstract

Premature atherosclerosis is often found in patients with diabetes mellitus (DM) type I, and alterations in lipid metabolism seem to play an important role in the development of this complication. Intensified insulin therapy improves glycemic control parameters significantly. To evaluate the effect of this optimized insulin treatment (OIT) not only on glycemic control, but also on plasma lipids, 24 patients with DM type I (19 men and 5 women, 18 to 61 years) were switched from a standard insulin therapy to a regimen of OIT which has been maintained for more than 3 years now. After 2 years on OIT a reduction of HbA1c values from 8.1% to 7.5% (p less than 0.01) was accompanied by an increase in HDL cholesterol from 52 to 67 mg/dl (p less than 0.05) and a decrease of triglyceride levels from 319 to 67 mg/dl (p less than 0.001). At the end of the second year on OIT some of the patients exhibited a reversal of the favorable trend in HbA1c and lipid values. Intensified instructions regarding the implementation of OIT were therefore repeated and resulted in a renewed improvement of overall HbA1c, HDL cholesterol and triglyceride levels to 6.43%, 67 mg/dl, and 78 mg/dl, respectively. Our findings underline the value of OIT not only for glycemic control, but also for the control of plasma lipids considered to be major risk factors for coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921231     DOI: 10.1007/bf01649419

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Hyperlipidemia and the control of diabetes mellitus.

Authors:  A L Drash
Journal:  Am J Dis Child       Date:  1976-10

Review 2.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

3.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

4.  [Insulin therapy: the basis-bolus principle].

Authors:  B Teupe; K Bergis
Journal:  Dtsch Med Wochenschr       Date:  1987-07-24       Impact factor: 0.628

5.  Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus.

Authors:  F L Dunn; A Pietri; P Raskin
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

6.  Juvenile diabetes mellitus and serum lipids and lipoprotein levels.

Authors:  H P Chase; A M Glasgow
Journal:  Am J Dis Child       Date:  1976-10

7.  Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes.

Authors:  J Rosenstock; G L Vega; P Raskin
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

8.  Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity.

Authors:  J L Witztum; E M Mahoney; M J Branks; M Fisher; R Elam; D Steinberg
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

9.  Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins.

Authors:  T J Lyons; R L Klein; J W Baynes; H C Stevenson; M F Lopes-Virella
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

10.  Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.

Authors:  E A Nikkilä; J K Huttunen; C Ehnholm
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.